证券代码：688371 证券简称：菲沃泰 公告编号：2023-030 江苏菲沃泰纳米科技股份有限公司 第一届监事会第十四次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会议召开情况 江苏菲沃泰纳米科技股份有限公司（以下简称"公司"）第一届监事会第十 四次会议于 2023 年 8 月 23 日在公司会议室以现场会议的方式召开。本次会议的 通知及会议资料已于 2023 年 8 月 23 日以专人送达的方式向全体监事送达。本次 会议为紧急会议，经全体监事一致同意豁免会议通知期限要求，与会的各位监事 已知悉与所议事项相关的必要信息。 本次会议应出席监事 3 人，实际出席监事 3 人，会议由监事会主席韦庆宇先 生主持。会议的召集和召开程序符合《中华人民共和国公司法》（以下简称"《公 司法》"）等有关法律法规、规范性文件和《江苏菲沃泰纳米科技股份有限公司 章程》的规定，会议决议合法、有效。 二、监事会会议审议情况 经全体监事表决，形成决议如下： （二）审议通过了《关于向 2023 年股票期权激励计划激励对象授予 ...

证券代码：688371 证券简称：菲沃泰 公告编号：2023-031 江苏菲沃泰纳米科技股份有限公司 关于调整 2023 年股票期权激励计划激励对象名单 及授予数量的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据江苏菲沃泰纳米科技股份有限公司（以下简称"公司"）2023 年第一次 临时股东大会授权，公司于 2023 年 8 月 23 日召开第一届董事会第十七次会议、 第一届监事会第十四次会议，审议通过了《关于调整 2023 年股票期权激励计划 相关事项的议案》，现将相关调整事项说明如下： 鉴于公司本激励计划拟授予的激励对象中有 2 名激励对象因个人原因离职， 上述共涉及股票期权 60 万份。董事会根据公司 2023 年第一次临时股东大会的授 权对本激励计划拟授予的激励对象名单及授予数量进行了调整。本次调整后，本 激励计划授予的激励对象由 36 名调整为 34 名，授予的股票期权数量由 2,120 万 份调整为 2,060 万份。 除上述调整内容外，本激励计划其他内容与公司 2023 年第一次临时股东大 会审议通 ...

江苏菲沃泰纳米科技股份有限公司 2023 年股票期权激励计划授予激励对象名单 （截止授予日） 2、上述任何一名激励对象通过全部在有效期内的股权激励计划获授的本公司股票均未超过公司总股 本的 1%。公司全部有效的激励计划所涉及的标的股票总数累计不超过股权激励计划提交股东大会时公司 股本总额的 20%。 在本激励计划授予的股票期权在各激励对象间的分配情况如下表所示： | | | | 获授的股票 | 占本激励计 | 占本激励计 | | --- | --- | --- | --- | --- | --- | | 姓名 | 国籍 | 职务 | 期权数量 | 划授出权益 | 划公告日股 | | | | | (万份) | 数量的比例 | 本总额比例 | | 一、董事、高级管理人员、核心技术人员 | | | | | | | 核心技术人员、深圳 | 兰竹瑶 中国 | 子公司总经理 | 180 | 8.74% | 0.54% | | 核心技术人员、产品 | 隋爱国 中国 | | 80 | 3.88% | 0.24% | | 研发中心总监 | | | | | | | 小计 | | | 260 | 12.62% | 0.78% | ...

证券代码：688371 证券简称：菲沃泰 公告编号：2023-032 江苏菲沃泰纳米科技股份有限公司 关于向 2023 年股票期权激励计划激励对象授予股 票期权的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 股票期权授予日：2023 年 8 月 23 日 股票期权授予数量：2,060 万份，占目前公司股本总额 33,547.2356 万股的 6.14% 股权激励方式：股票期权 《江苏菲沃泰纳米科技股份有限公司 2023 年股票期权激励计划（草案）》 （以下简称"《激励计划（草案）》"）规定的江苏菲沃泰纳米科技股份有限公 司（以下简称"公司"）2023 年股票期权激励计划（以下简称"本激励计划"） 的授予条件已经成就，根据公司 2023 年第一次临时股东大会授权，公司于 2023 年 8 月 23 日召开第一届董事会第十七次会议、第一届监事会第十四次会议，分 别审议通过了《关于向 2023 年股票期权激励计划激励对象授予股票期权的议案》， 确定 2022 年 8 月 23 日为授予日，向 34 名激励 ...

北京市中伦律师事务所 关于江苏菲沃泰纳米科技股份有限公司 2023 年股票期权激励计划调整及授予事项的 法律意见书 二〇二三年八月 北京市朝阳区金和东路 20 号院正大中心 3 号南塔 22-31 层 邮编：100020 22-31/F, South Tower of CP Center, 20 Jin He East Avenue, Chaoyang District, Beijing l00020, P.R. China 电话/Tel : +86 10 5957 2288 传真/Fax : +86 10 6568 1022/1838 www.zhonglun.com 北京市中伦律师事务所 关于江苏菲沃泰纳米科技股份有限公司 2023 年股票期权激励计划调整及授予事项的 法律意见书 致：江苏菲沃泰纳米科技股份有限公司 北京市中伦律师事务所（以下简称"本所"）接受江苏菲沃泰纳米科技股份有 限公司（以下简称"菲沃泰"或"公司"）委托，就公司 2023 年股票期权激励计划 （以下简称"激励计划"或"本次激励计划"）相关事宜担任专项法律顾问，并就本 次激励计划调整（以下简称"本次调整事项"）及授予（以下简称"本次授 ...

江苏菲沃泰纳米科技股份有限公司独立董事 关于第一届董事会第十七次会议相关事项的独立意见 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和 国证券法》（以下简称"《证券法》"）、《上市公司股权激励管理办法》（以下简称 "《管理办法》"）、《上海证券交易所科创板股票上市规则》（以下简称"《上市规 则》"）、《上市公司独立董事规则》等法律、法规以及《江苏菲沃泰纳米科技股 份有限公司章程》（以下简称"《公司章程》"）等的相关规定，作为江苏菲沃泰 纳米科技股份有限公司（以下简称"公司"）的独立董事，对第一届董事会第十 七次会议审议的相关事项在查阅公司提供的相关资料、了解相关情况后，基于 独立判断的立场，发表独立意见如下： 一、《关于调整 2023 年股票期权激励计划相关事项的议案》的独立意见 经审议，独立董事认为： 规以及《激励计划（草案）》中关于授予日的规定。 （2）未发现公司存在《管理办法》等法律、法规和规范性文件规定的禁止 实施股权激励计划的情形，公司具备实施股权激励计划的主体资格。 （3）公司确定授予的激励对象均具备《公司法》《证券法》等法律、法规、 规范性文件以及《公司章程》规定的任职资 ...

Financial Performance - The company reported a significant increase in revenue for the first half of 2023, achieving a total of 500 million RMB, representing a growth of 25% compared to the same period last year[1]. - The company's operating revenue for the first half of 2023 was approximately ¥119.37 million, a decrease of 36.16% compared to ¥186.98 million in the same period last year[24]. - The net profit attributable to shareholders of the listed company was approximately -¥21.45 million, a decline of 555.10% from a profit of ¥4.71 million in the previous year[24]. - Basic earnings per share for the first half of 2023 were -¥0.06, representing a 400.00% decrease from ¥0.02 in the same period last year[23]. - The company reported a significant decline in net profit after excluding non-recurring gains and losses, with a net profit of approximately -¥44.87 million compared to -¥4.63 million in the previous year[24]. - The company experienced a substantial drop in net profit attributable to the parent company, which fell by 77.79% to approximately ¥7.76 million from ¥34.93 million in the previous year[24]. - The company achieved operating revenue of 119.368 million yuan, a year-on-year decrease of 36.16%[95]. - The net profit attributable to the parent company was -21.4538 million yuan, a year-on-year decrease of 555.10%[95]. Research and Development - Research and development investments have increased by 30%, focusing on innovative applications of nanotechnology in various industries[1]. - The company's research and development expenditure accounted for 34.61% of operating revenue, an increase of 21.86 percentage points compared to 12.75% in the previous year[23]. - The company plans to expand its research and development pipeline and increase investment in R&D to enhance future growth prospects[25]. - The company achieved a 73.21% increase in R&D expenses, totaling approximately ¥41.31 million compared to ¥23.85 million in the previous year[74]. - R&D expenses accounted for 34.61% of total revenue, an increase of 21.86 percentage points from 12.75% in the previous year[74]. - The company applied for 45 new intellectual property rights during the reporting period, including 36 invention patents and 4 utility model patents, bringing the total to 281 intellectual property rights[73]. - The company has developed 12 core technologies, including plasma stability control technology and advanced plasma chemical vapor deposition equipment design technology, maintaining its leading position in the domestic nano-protection field[71]. Market Expansion and Strategy - The company is actively pursuing market expansion strategies, targeting Southeast Asia with plans to establish a local office by Q4 2023[1]. - The company aims to strengthen its R&D platform and team to develop more proprietary nanofilm products, consolidating its technological leadership in the industry[37]. - The company is focused on increasing its market share in downstream sectors by expanding its sales team and enhancing customer engagement[37]. - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by the end of 2024[156]. - The company completed a strategic acquisition of a tech startup for 200 million, aimed at enhancing its product offerings[156]. Product Development and Innovation - New product launches include a cutting-edge nano-coating technology that is expected to enhance product performance and attract new customers[1]. - The PECVD nanofilm technology significantly enhances waterproof performance while reducing the need for structural protection, leading to cost savings[36]. - The company provides high-performance, multifunctional nanofilm products that offer waterproof, oil-proof, corrosion-resistant, and scratch-resistant features for various applications[39]. - The company has developed a comprehensive material formulation system for nano-coating products, including single-layer, double-layer, and multi-layer nano-films tailored to various industry needs[41]. - The company has introduced a silicon-based hard coating that enhances surface hardness and scratch resistance, applicable to automotive parts and foldable smartphone covers[44]. Sustainability and Compliance - The management highlighted the importance of sustainability initiatives, aiming to reduce carbon emissions by 10% by the end of 2023[1]. - The company reduced carbon emissions by 238.52 tons through various carbon reduction measures[145]. - The company received administrative penalties totaling 202,692.9 RMB for environmental compliance issues[142]. Legal and Regulatory Matters - The board of directors confirmed that there are no significant legal or regulatory issues affecting the company's operations[1]. - The company is involved in a significant lawsuit regarding patent infringement, with the case currently under review by the Supreme Court[199]. - The company has confirmed that there are no undisclosed or subsequent developments in litigation or arbitration matters[200]. Shareholder and Governance - The company launched a stock option incentive plan in June 2023 to enhance talent retention and motivation[93]. - The company commits to not transferring or entrusting the management of its shares within 36 months from the completion of the capital increase registration and 12 months from the stock listing[163]. - The company will not distribute profits or increase capital reserves in the first half of 2023[138]. - The company has established a stock price stabilization plan to protect shareholders, especially minority shareholders, for three years post-IPO[174].

一、《关于公司<2023 年半年度募集资金存放与实际使用情况的专项报告> 的议案》的独立意见 经审议，独立董事认为： 我们认为，公司 2023 年半年度募集资金存放与使用情况符合有关法律、法 规和公司《募集资金使用管理办法》的规定，公司《2023 年半年度募集资金存 放与实际使用情况的专项报告》真实地反映了公司募集资金存放、使用、管理情 况，不存在变相改变募集资金用途和损害股东利益的情况，不存在变相改变募集 资金存放和使用违规的情形。报告内容真实、准确、完整，我们同意公司《2023 年半年度募集资金存放与实际使用情况的专项报告》。 二、《关于使用暂时闲置募集资金及自有资金进行现金管理的议案》的独立 意见 江苏菲沃泰纳米科技股份有限公司独立董事 关于第一届董事会第十六次会议相关事项的独立意见 根据《中华人民共和国公司法》《上市公司独立董事规则》《上海证券交易所 科创板股票上市规则》及《江苏菲沃泰纳米科技股份有限公司章程》（以下简称 "《公司章程》"）等的相关规定，作为江苏菲沃泰纳米科技股份有限公司（以下 简称"公司"）的独立董事，对第一届董事会第十六次会议审议的相关事项在查 阅公司提供的相关资料、了解相关情况后 ...

证券代码：688371 证券简称：菲沃泰 公告编号：2023-013 江苏菲沃泰纳米科技股份有限公司 关于召开 2022 年度暨 2023 年第一季度业绩说明会 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 投资者可于 2023 年 5 月 11 日(星期四) 至 5 月 17 日(星期三)16:00 前登录 上 证 路 演 中 心 网 站 首 页 点 击 " 提 问 预 征 集 " 栏 目 或 通 过 公 司 邮 箱 ft- board@favoredtech.com 进行提问。公司将在说明会上对投资者普遍关注的问题 进行回答。 一、说明会类型 本次投资者说明会以网络互动形式召开，公司将针对 2022 年度以及 2023 年 第一季度的经营成果及财务指标的具体情况与投资者进行互动交流和沟通，在信 息披露允许的范围内就投资者普遍关注的问题进行回答。 会议召开时间：2023 年 5 月 18 日(星期四)下午 13:00-14:00 会议召开地点：上海证券交易所上证路演中心 （网址：http:// ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥57,807,045.04, representing a decrease of 39.72% compared to the same period last year[5] - The net profit attributable to shareholders was -¥10,670,029.39, a decline of 237.59% year-over-year[5] - The basic and diluted earnings per share were both -¥0.03, a decrease of 206.02% compared to the previous year[6] - Net profit for Q1 2023 was -¥10,670,029.39, a decline from a profit of ¥7,754,728.06 in Q1 2022[22] - Operating profit for Q1 2023 was -¥18,060,768.25, compared to a profit of ¥2,583,717.90 in Q1 2022[21] Cash Flow - The net cash flow from operating activities increased by 36.27% to ¥38,367,285.32, primarily due to a reduction in cash payments for goods and services[6] - The company’s cash flow from operating activities showed a net outflow, indicating challenges in cash generation during the quarter[23] - In Q1 2023, the cash inflow from operating activities was CNY 123,706,476.55, a decrease of 3.3% compared to CNY 128,133,349.80 in Q1 2022[24] - The net cash flow from investment activities was CNY 3,215,541.31, recovering from a negative CNY 56,590,533.77 in Q1 2022[25] - The total cash and cash equivalents at the end of Q1 2023 reached CNY 218,896,177.96, up from CNY 75,359,721.57 at the end of Q1 2022[25] Research and Development - Research and development expenses totaled ¥18,158,152.56, an increase of 50.20%, reflecting the company's efforts to expand its R&D pipeline[6] - The proportion of R&D expenses to operating revenue was 31.41%, an increase of 18.81 percentage points compared to the previous year[6] - The company reported a significant increase in R&D expenses, totaling ¥18,158,152.56, up from ¥12,088,982.58 in Q1 2022, reflecting a focus on innovation[21] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,080,044,356.65, a slight decrease of 0.60% from the end of the previous year[6] - Non-current assets totaled ¥666,827,220.13, an increase from ¥618,283,642.00 in the previous period[21] - Total current assets decreased to ¥1,413,217,136.52 from ¥1,474,262,174.80 at the end of 2022, reflecting a decline of approximately 4.14%[16] - Total liabilities amounted to ¥91,611,696.52, down from ¥107,641,622.37 in the previous period[18] Shareholder Information - Total number of common shareholders at the end of the reporting period was 10,943[13] - The largest shareholder, Favored Tech Corporation, holds 208,533,334 shares, representing 62.16% of total shares[13] - The top ten shareholders include various investment funds and individuals, with significant holdings in common shares[14] Other Information - The company has not disclosed any new product developments or market expansion strategies in the current report[15] - There are no significant changes in the audit opinion type for the financial statements, remaining unaudited[16] - The company reported non-recurring gains and losses totaling ¥13,976,367.94 for the period[9] - The company experienced a foreign exchange loss of CNY 765,582.07, compared to a loss of CNY 675,377.77 in the same quarter last year[25]